Skip to main
TARO
TARO logo

TARO Earnings Dates & Reports

TARO Most Recent Earnings

Report DateJan 25, 2024
Period EndingQ3 2024
Est. EPS$0.30
Actual EPS$0.56
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

TARO Earnings per Share (EPS) History

Signup for full access
Browse free

TARO Latest Earnings

The value each TARO share was expected to gain vs. the value each share gained.

TARO reported its most recent earnings on Jan 25, 2024 for Q3 2024, posting earnings per share (EPS) of $0.56. This exceeded analysts' expectations of $0.30 by 86.67%, marking a Beat.

For comparison, Taro Pharmaceutical Industries reported EPS of $0.19 in the same quarter last year.

The company is expected to announce its next earnings report on 05/20/2024, with analysts projecting an EPS of $0.

TARO Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2024May 20, 2024
$0.43
DeckReportListen
Q3 2024Jan 25, 2024
$0.30$0.56+86.67%
DeckReportListen
Q2 2024Oct 26, 2023
$0.18$0.38+111.11%
DeckReportListen
Q1 2024Jul 26, 2023
$0.31$0.40+29.03%
DeckReportListen
Q4 2023May 23, 2023
$0.31$0.18-41.94%
DeckReportListen
View all

TARO Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Taro Pharmaceutical Industries’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Jan 25, 2024
Oct 26, 2023
Jul 26, 2023
May 23, 2023

TARO Earnings FAQs

TARO last reported earnings on Jan 25, 2024 for Q3 2024, posting an EPS of $0.56, which Beat the estimate of $0.30 by 86.67%.

For Q3 2024, TARO reported an EPS of $0.56, exceeding analysts' estimate of $0.30 by 86.67%.

For Q3 2024, TARO Beat expectations with an actual EPS of $0.56 vs. an estimated EPS of $0.30.

Following the last earnings report on Jan 25, 2024, TARO's stock price moved — from — to —.

The next TARO earnings call is scheduled for May. 20, 2024, where executives will discuss financial results and outlook.

Taro Pharmaceutical Industries (TARO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.